West Pharmaceutical Services (NYSE:WST) announced that it completed the sale of its SmartDose on-body delivery system to AbbVie. Exton, Pennsylvania-based West sold and transferred its manufacturing and supply rights for the SmartDose 3.5mL on-body delivery system and associated facilities to AbbVie. The companies closed their transaction, as planned, on July 1, 2026. West will continue […]
West Pharmaceutical
West Pharmaceutical Services opens expanded Dublin facility for injectable therapies
West Pharmaceutical Services (NYSE:WST) announced the opening of a new facility for contract services in Dublin, Ireland. IDA Ireland, the foreign direct investment arm for the Irish government, shared the announcement of the Damastown site’s opening. The 165,000-square-foot expansion enhances West’s contract services. It helps meet the growing demand for high-volume treatments, including for diabetes […]
West sells manufacturing, supply rights for on-body drug delivery system to AbbVie
West Pharmaceutical Services (NYSE:WST) announced that it reached an agreement to sell on-body drug delivery technology to AbbVie. The company agreed to sell all manufacturing and supply rights for the SmartDose 3.5mL on-body system and associated facilities. Exton, Pennsylvania-based West said the deal includes a total consideration of $112.5 million at close. It expects the […]
West Pharmaceutical stock skyrockets on Street-beating Q4
West Pharmaceutical Services (NYSE:WST) shares received a massive boost today on fourth-quarter results that beat the consensus forecast. Shares of WST rose 15.5% at $322.53 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 10.1%. The Exton, Pennsylvania-based drug delivery device maker […]
West, Corning expand partnership on drug delivery, packaging solutions
West Pharmaceutical Services (NYSE:WST) announced today that it expanded its ongoing collaboration with Corning (NYSE:GLW). Exton, Pennsylvania-based West said its partnership now includes exclusive distribution rights for Corning Valor glass vials. It also includes the launch of its first product, West Ready Pack with Corning Valor RTU vials. This technology utilizes SG EZ-fill technology. The […]
West Pharmaceutical stock ticks up on Street-beating Q2 despite lowered guidance
West Pharmaceutical Services (NYSE:WST) shares rose before hours on second-quarter results that came in ahead of the consensus forecast. The Exton, Pennsylvania–based company posted profits of $188.5 million, or $2.48 per share, on sales of $771.3 million for the three months ended June 30, 2022, for a 0.6% bottom-line gain on sales growth of 6.6%. […]
West Pharmaceutical Services debuts new needle syringe system
West Pharmaceutical Services (NYSE:WST) announced the recent unveiling of its Daikyo Crystal Zenith needle syringe system. Exton, Pennsylvania–based West designed the Daikyo Crystal Zenith 2.25mL insert needle syringe system as a technologically advanced cyclic olefin polymer containment and delivery system. It’s meant to offer an alternative to glass, mitigating the risk of breakage and reducing […]
West Pharmaceutical Services beats Street in Q3, raises guidance
West Pharmaceutical Services (NYSE:WST) shares rose slightly today on third-quarter results that topped the consensus forecast. The Exton, Pennsylvania-based maker of injectable drug packaging and delivery systems posted profits of $175.6 million, or $2.31 per share, on sales of $706.5 million for the three months ended Sept. 30, 2021, more than doubling its bottom-line on […]
West Pharmaceutial Services beats The Street, raises guidance
West Pharmaceutical Services (NYSE:WST) shares ticked up before hours on second-quarter results that beat the consensus forecast. The Exton, Pa.-based company posted profits of $187.3 million, or $2.47 per share, on sales of $723.6 million for the three months ended June 30, 2021, more than doubling its bottom-line on sales growth of 37.3%. Adjusted to […]
West Pharmaceutical Services beats Street in Q1, raises guidance
West Pharmaceutical Services (NYSE:WST) posted Street-beating first-quarter financial results and raised its full-year guidance for 2021. The Exton, Pa.-based company posted profits of $151.2 million, or $1.99 per share, on sales of $670.7 million for the three months ended March 31, 2021, more than doubling its bottom-line on sales growth of 36.5%. Adjusted to exclude […]
